94 related articles for article (PubMed ID: 10912945)
1. Correspondence re: Varma M, Linden MD, Amin MB. Effect of formalin fixation and epitope retrieval techniques on antibody 34betaE12 immunostaining of prostatic tissues. Mod Pathol 1999;12:472-8.
Gown AM; Yaziji H; Battifora H
Mod Pathol; 2000 Jul; 13(7):834-5. PubMed ID: 10912945
[No Abstract] [Full Text] [Related]
2. Effect of formalin fixation and epitope retrieval techniques on antibody 34betaE12 immunostaining of prostatic tissues.
Varma M; Linden MD; Amin MB
Mod Pathol; 1999 May; 12(5):472-8. PubMed ID: 10349984
[TBL] [Abstract][Full Text] [Related]
3. Basal cell-specific anti-keratin antibody 34betaE12: optimizing its use in distinguishing benign prostate and cancer.
Ramnani DM; Bostwick DG
Mod Pathol; 1999 May; 12(5):443-4. PubMed ID: 10349979
[No Abstract] [Full Text] [Related]
4. Formalin fixation and immunoreactivity in prostate cancer and benign prostatic tissues.
Jaraj SJ; Egevad L
APMIS; 2010 May; 118(5):383-8. PubMed ID: 20477814
[TBL] [Abstract][Full Text] [Related]
5. Correspondence re: Shah IA, Schlageter M-O, Stinnet P, Lechago J: Cytokeratin immunohistochemistry as a diagnostic tool for distinguishing malignant from benign epithelial lesions of the prostate. Mod Pathol 4:220, 1991.
Bacchi CE; Gown AM
Mod Pathol; 1992 Nov; 5(6):686-7. PubMed ID: 1285445
[No Abstract] [Full Text] [Related]
6. Quantitative fluorescence imaging analysis for cancer biomarker discovery: application to beta-catenin in archived prostate specimens.
Huang D; Casale GP; Tian J; Wehbi NK; Abrahams NA; Kaleem Z; Smith LM; Johansson SL; Elkahwaji JE; Hemstreet GP
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1371-81. PubMed ID: 17623804
[TBL] [Abstract][Full Text] [Related]
7. A molecular mechanism of formalin fixation and antigen retrieval.
Sompuram SR; Vani K; Messana E; Bogen SA
Am J Clin Pathol; 2004 Feb; 121(2):190-9. PubMed ID: 14983931
[TBL] [Abstract][Full Text] [Related]
8. Expression of a novel biomarker, EPCA, in adenocarcinomas and precancerous lesions in the prostate.
Uetsuki H; Tsunemori H; Taoka R; Haba R; Ishikawa M; Kakehi Y
J Urol; 2005 Aug; 174(2):514-8. PubMed ID: 16006883
[TBL] [Abstract][Full Text] [Related]
9. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
[TBL] [Abstract][Full Text] [Related]
10. Targeting epitopes in prostate-specific membrane antigen for antibody therapy of prostate cancer.
Kinoshita Y; Kuratsukuri K; Newman N; Rovito PM; Kaumaya PT; Wang CY; Haas GP
Prostate Cancer Prostatic Dis; 2005; 8(4):359-63. PubMed ID: 16172607
[TBL] [Abstract][Full Text] [Related]
11. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.
Sinha AA; Quast BJ; Reddy PK; Lall V; Wilson MJ; Qian J; Bostwick DG
Exp Mol Pathol; 2004 Oct; 77(2):153-9. PubMed ID: 15351240
[TBL] [Abstract][Full Text] [Related]
12. Rapid microwave-stimulated fixation of entire prostatectomy specimens. Biomed-II MPC Study Group.
Ruijter ET; Miller GJ; Aalders TW; van de Kaa CA; Schalken JA; Debruyne FM; Boon ME
J Pathol; 1997 Nov; 183(3):369-75. PubMed ID: 9422995
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody (F5) to human prostate antigen.
Papsidero LD; Croghan GA; Wang MC; Kuriyama M; Johnson EA; Valenzuela LA; Chu TM
Hybridoma; 1983; 2(2):139-47. PubMed ID: 6205972
[TBL] [Abstract][Full Text] [Related]
14. Antibodies immunoreactive with formalin-fixed tissue antigens recognize linear protein epitopes.
Sompuram SR; Vani K; Hafer LJ; Bogen SA
Am J Clin Pathol; 2006 Jan; 125(1):82-90. PubMed ID: 16482995
[TBL] [Abstract][Full Text] [Related]
15. Limiting the diagnosis of atypical small glandular proliferations in needle biopsies of the prostate by the use of immunohistochemistry.
Helpap B; Köllermann J; Oehler U
J Pathol; 2001 Mar; 193(3):350-3. PubMed ID: 11241415
[TBL] [Abstract][Full Text] [Related]
16. [Antigenic specificity of the prostate].
Emile C
Rev Infirm; 2008 Jun; (141):45-6. PubMed ID: 18669391
[No Abstract] [Full Text] [Related]
17. Prostate secretory granules in normal and neoplastic prostate glands: a diagnostic aid to needle biopsy.
Cohen RJ; Beales MP; McNeal JE
Hum Pathol; 2000 Dec; 31(12):1515-9. PubMed ID: 11150377
[TBL] [Abstract][Full Text] [Related]
18. Comparison of monoclonal antibody (P504S) and polyclonal antibody to alpha methylacyl-CoA racemase (AMACR) in the work-up of prostate cancer.
Kunju LP; Chinnaiyan AM; Shah RB
Histopathology; 2005 Dec; 47(6):587-96. PubMed ID: 16324196
[TBL] [Abstract][Full Text] [Related]
19. Correspondence re: Tatusuo Tomita, Timothy Dalton, Simon Kwok, Saing Lee, Mark Noble, and Masahiro Chiga. Profile of prostatic-specific antigen in prostatic carcinomas. Mod Pathol 6:259, 1993.
Pretlow TG
Mod Pathol; 1994 Jan; 7(1):146-8. PubMed ID: 7512717
[No Abstract] [Full Text] [Related]
20. Unmasking the mysteries of antigen or epitope retrieval and formalin fixation.
Gown AM
Am J Clin Pathol; 2004 Feb; 121(2):172-4. PubMed ID: 14983929
[No Abstract] [Full Text] [Related]
[Next] [New Search]
